InflaRx Ownership 2024 | Who Owns InflaRx Now?
Institutional Ownership
25.18%
Insider Ownership
7.34%
Retail Ownership
67.48%
Institutional Holders
37.00
InflaRx Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10.44% | 0.33% | 5,733,910 | - | - | 8,830,221 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 2.38% | 0.13% | 1,305,140 | - | - | 2,009,916 | Mar 31, 2024 |
| CITIGROUP INC | 2.19% | 0.00% | 1,201,301 | - | - | 1,850,004 | Mar 31, 2024 |
| MORGAN STANLEY | 1.78% | 0.00% | 978,521 | 55,700 | 6.04% | 1,506,923 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 1.58% | 0.10% | 870,000 | - | - | 1,339,800 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.40% | 0.12% | 769,065 | -1,104,688 | -58.96% | 1,184,360 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 1.28% | 0.12% | 704,987 | 16,383 | 2.38% | 1,085,680 | Mar 31, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.70% | 0.00% | 384,972 | 67,113 | 21.11% | 592,857 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.70% | 0.04% | 382,409 | 180,529 | 89.42% | 588,910 | Mar 31, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.44% | 0.00% | 242,620 | 67,341 | 38.42% | 373,635 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 194,465 | 194,465 | 100.00% | 299,476 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 0.00% | 158,035 | 16,383 | 11.57% | 243,374 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.25% | 0.00% | 139,957 | -140,975 | -50.18% | 215,534 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 102,215 | -36,160 | -26.13% | 157,411 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.18% | - | 97,984 | 85,121 | 661.75% | 150,895 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.15% | 0.00% | 81,819 | 45,818 | 127.27% | 126,002 | Mar 31, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.14% | 0.01% | 75,100 | - | - | 116,000 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.13% | 0.00% | 70,000 | 70,000 | 100.00% | 108,000 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.09% | 0.06% | 50,000 | - | - | 77,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.08% | - | 46,515 | 46,515 | 100.00% | 71,633 | Mar 31, 2024 |
InflaRx's largest institutional shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC, holding 10.44% of the company's total share outstanding, currently valued at $8.83M. The top 10 institutional shareholders own together 22.88% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10.44% | 0.33% | 5,733,910 | - | - | 8,830,221 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 2.38% | 0.13% | 1,305,140 | - | - | 2,009,916 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.40% | 0.12% | 769,065 | -1,104,688 | -58.96% | 1,184,360 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 1.28% | 0.12% | 704,987 | 16,383 | 2.38% | 1,085,680 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 1.58% | 0.10% | 870,000 | - | - | 1,339,800 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.09% | 0.06% | 50,000 | - | - | 77,000 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.70% | 0.04% | 382,409 | 180,529 | 89.42% | 588,910 | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 194,465 | 194,465 | 100.00% | 299,476 | Mar 31, 2024 |
| PACIFICA PARTNERS INC. | 0.04% | 0.01% | 20,585 | - | - | 31,675 | Mar 31, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.14% | 0.01% | 75,100 | - | - | 116,000 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 23,153 | 23,153 | 100.00% | 35,656 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 0.00% | 158,035 | 16,383 | 11.57% | 243,374 | Mar 31, 2024 |
| WETZEL INVESTMENT ADVISORS, INC. | 0.00% | 0.00% | 2,000 | 1,000 | 100.00% | 2,520 | Mar 31, 2024 |
| CITIGROUP INC | 2.19% | 0.00% | 1,201,301 | - | - | 1,850,004 | Mar 31, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.70% | 0.00% | 384,972 | 67,113 | 21.11% | 592,857 | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | 0.02% | 0.00% | 12,251 | 12,251 | 100.00% | 18,867 | Mar 31, 2024 |
| TOROSO INVESTMENTS, LLC | 0.03% | 0.00% | 15,153 | 15,153 | 100.00% | 23,336 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 102,215 | -36,160 | -26.13% | 157,411 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 8,466 | 2,545 | 42.98% | 13,038 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 25,700 | -2,000 | -7.22% | 39,578 | Mar 31, 2024 |
The largest InflaRx shareholder by % of total assets is SUVRETTA CAPITAL MANAGEMENT, LLC. The company owns 5.73M shares of InflaRx (IFRX), representing 0.33% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 194,465 | 194,465 | 100.00% | 299,476 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.70% | 0.04% | 382,409 | 180,529 | 89.42% | 588,910 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.18% | - | 97,984 | 85,121 | 661.75% | 150,895 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.13% | 0.00% | 70,000 | 70,000 | 100.00% | 108,000 | Mar 31, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.44% | 0.00% | 242,620 | 67,341 | 38.42% | 373,635 | Mar 31, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.70% | 0.00% | 384,972 | 67,113 | 21.11% | 592,857 | Mar 31, 2024 |
| MORGAN STANLEY | 1.78% | 0.00% | 978,521 | 55,700 | 6.04% | 1,506,923 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.08% | - | 46,515 | 46,515 | 100.00% | 71,633 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.15% | 0.00% | 81,819 | 45,818 | 127.27% | 126,002 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 23,153 | 23,153 | 100.00% | 35,656 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 0.00% | 158,035 | 16,383 | 11.57% | 243,374 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 1.28% | 0.12% | 704,987 | 16,383 | 2.38% | 1,085,680 | Mar 31, 2024 |
| TOROSO INVESTMENTS, LLC | 0.03% | 0.00% | 15,153 | 15,153 | 100.00% | 23,336 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 12,534 | 12,534 | 100.00% | 19,302 | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | 0.02% | 0.00% | 12,251 | 12,251 | 100.00% | 18,867 | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | 0.03% | - | 16,865 | 5,213 | 44.74% | 25,972 | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.04% | - | 21,280 | 2,785 | 15.06% | 32,771 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 8,466 | 2,545 | 42.98% | 13,038 | Mar 31, 2024 |
| WETZEL INVESTMENT ADVISORS, INC. | 0.00% | 0.00% | 2,000 | 1,000 | 100.00% | 2,520 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 770 | 770 | 100.00% | 1,186 | Mar 31, 2024 |
As of Mar 31 2024, InflaRx's largest institutional buyer is PRELUDE CAPITAL MANAGEMENT, LLC. The company purchased 194.47K stocks of IFRX, valued at $299.48K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -2,206,893 | -100.00% | - | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.40% | 0.12% | 769,065 | -1,104,688 | -58.96% | 1,184,360 | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -320,246 | -100.00% | - | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -200,097 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.25% | 0.00% | 139,957 | -140,975 | -50.18% | 215,534 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 102,215 | -36,160 | -26.13% | 157,411 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -24,900 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -6,705 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -5,600 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.06% | - | 34,658 | -4,472 | -11.43% | 53,374 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 25,700 | -2,000 | -7.22% | 39,578 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,571 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -645 | -100.00% | - | Mar 31, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10.44% | 0.33% | 5,733,910 | - | - | 8,830,221 | Mar 31, 2024 |
| EVERSEPT PARTNERS, LP | 2.38% | 0.13% | 1,305,140 | - | - | 2,009,916 | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 1.58% | 0.10% | 870,000 | - | - | 1,339,800 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.09% | 0.06% | 50,000 | - | - | 77,000 | Mar 31, 2024 |
| PACIFICA PARTNERS INC. | 0.04% | 0.01% | 20,585 | - | - | 31,675 | Mar 31, 2024 |
| FRANKLIN STREET ADVISORS INC /NC | 0.14% | 0.01% | 75,100 | - | - | 116,000 | Mar 31, 2024 |
| CITIGROUP INC | 2.19% | 0.00% | 1,201,301 | - | - | 1,850,004 | Mar 31, 2024 |
As of Mar 31 2024, InflaRx's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -2.21M shares of IFRX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 0.13% | 0.00% | 70,000 | 70,000 | 100.00% | 108,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.08% | - | 46,515 | 46,515 | 100.00% | 71,633 | Mar 31, 2024 |
| TOROSO INVESTMENTS, LLC | 0.03% | 0.00% | 15,153 | 15,153 | 100.00% | 23,336 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 12,534 | 12,534 | 100.00% | 19,302 | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | 0.02% | 0.00% | 12,251 | 12,251 | 100.00% | 18,867 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 770 | 770 | 100.00% | 1,186 | Mar 31, 2024 |
InflaRx's largest new institutional shareholder by number of shares is COMMONWEALTH EQUITY SERVICES, LLC, purchased 70.00K shares, valued at $108.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -2,206,893 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -320,246 | -100.00% | - | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -200,097 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -24,900 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -6,705 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -5,600 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,571 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -645 | -100.00% | - | Mar 31, 2024 |
InflaRx's largest sold out institutional shareholder by shares sold is POINT72 ASSET MANAGEMENT, L.P., sold -2.21M shares, valued at -, as of undefined.
InflaRx Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 277,925 | 100,289 | 56.46% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 41,599 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 34,200 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 13,965 | - | - | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 3,000 | - | - | Dec 31, 2023 |
InflaRx's largest mutual fund holder by % of total assets is "INVESCO EXCHANGE-TRADED FUND TRUST", owning 277.93K shares, compromising 0.00% of its total assets.
InflaRx Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 37 | -5.13% |
| 31 Dec, 23 | 39 | -7.14% |
| 30 Sep, 23 | 42 | 13.51% |
| 30 Jun, 23 | 37 | 48.00% |
| 31 Mar, 23 | 25 | -24.24% |
| 31 Dec, 22 | 33 | 22.22% |
| 30 Sep, 22 | 27 | 12.50% |
| 30 Jun, 22 | 24 | -25.00% |
| 31 Mar, 22 | 32 | -17.95% |
| 31 Dec, 21 | 39 | 11.43% |
| 30 Sep, 21 | 35 | -2.78% |
| 30 Jun, 21 | 36 | -7.69% |
| 31 Mar, 21 | 39 | 30.00% |
| 31 Dec, 20 | 30 | 30.43% |
| 30 Sep, 20 | 23 | -30.30% |
| 30 Jun, 20 | 33 | 50.00% |
| 31 Mar, 20 | 22 | 15.79% |
| 31 Dec, 19 | 19 | 11.76% |
| 30 Sep, 19 | 17 | -39.29% |
| 30 Jun, 19 | 28 | -39.13% |
| 31 Mar, 19 | 46 | 35.29% |
| 31 Dec, 18 | 34 | -10.53% |
| 30 Sep, 18 | 38 | 15.15% |
| 30 Jun, 18 | 33 | 17.86% |
| 31 Mar, 18 | 28 | 55.56% |
| 31 Dec, 17 | 18 | - |
As of 31 Mar 24, 37 institutions are holding InflaRx's shares, representing a decrease of -5.13% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 13,833,566 | -18.55% |
| 31 Dec, 23 | 16,983,545 | -10.14% |
| 30 Sep, 23 | 18,900,427 | 3.39% |
| 30 Jun, 23 | 18,281,096 | 434.94% |
| 31 Mar, 23 | 3,417,427 | -5.56% |
| 31 Dec, 22 | 3,618,593 | -6.12% |
| 30 Sep, 22 | 3,854,596 | -24.75% |
| 30 Jun, 22 | 5,122,402 | -19.31% |
| 31 Mar, 22 | 6,347,934 | -31.30% |
| 31 Dec, 21 | 9,240,311 | 4.53% |
| 30 Sep, 21 | 8,840,261 | -20.55% |
| 30 Jun, 21 | 11,127,489 | -18.37% |
| 31 Mar, 21 | 13,631,901 | 296.70% |
| 31 Dec, 20 | 3,436,304 | -1.96% |
| 30 Sep, 20 | 3,505,012 | 2.62% |
| 30 Jun, 20 | 3,415,584 | -31.93% |
| 31 Mar, 20 | 5,017,755 | -5.13% |
| 31 Dec, 19 | 5,289,055 | 16.51% |
| 30 Sep, 19 | 4,539,544 | 2.48% |
| 30 Jun, 19 | 4,429,492 | -69.47% |
| 31 Mar, 19 | 14,509,056 | 9.57% |
| 31 Dec, 18 | 13,241,403 | -0.98% |
| 30 Sep, 18 | 13,372,824 | 4.23% |
| 30 Jun, 18 | 12,829,829 | 29.91% |
| 31 Mar, 18 | 9,876,168 | -2.63% |
| 31 Dec, 17 | 10,142,925 | - |
InflaRx (IFRX) has 13.83M shares outstanding as of 31 Mar 24, down -18.55% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 25.18% | 3.03% |
| 31 Dec, 23 | 28.84% | 2.62% |
| 30 Sep, 23 | 33.17% | 1.99% |
| 30 Jun, 23 | 40.83% | 70.08% |
| 31 Mar, 23 | 7.63% | 11.39% |
| 31 Dec, 22 | 8.19% | 10.76% |
| 30 Sep, 22 | 8.72% | 6.49% |
| 30 Jun, 22 | 11.59% | 5.62% |
| 31 Mar, 22 | 14.36% | 2.91% |
| 31 Dec, 21 | 22.20% | 5.55% |
| 30 Sep, 21 | 20.01% | 3.15% |
| 30 Jun, 21 | 25.18% | 1.55% |
| 31 Mar, 21 | 40.32% | 23.39% |
| 31 Dec, 20 | 13.13% | 8.22% |
| 30 Sep, 20 | 12.64% | 7.42% |
| 30 Jun, 20 | 13.05% | 3.53% |
| 31 Mar, 20 | 19.22% | 4.68% |
| 31 Dec, 19 | 20.26% | 6.64% |
| 30 Sep, 19 | 17.47% | 6.00% |
| 30 Jun, 19 | 17.06% | 0.55% |
| 31 Mar, 19 | 55.88% | 2.01% |
| 31 Dec, 18 | 52.77% | 1.94% |
| 30 Sep, 18 | 52.11% | 1.89% |
| 30 Jun, 18 | 52.52% | 3.05% |
| 31 Mar, 18 | 41.48% | 2.21% |
| 31 Dec, 17 | 43.33% | - |
As of 31 Mar 24, InflaRx is held by 25.18% institutional shareholders, representing a 3.03% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 20 | 25.00% |
| 31 Dec, 23 | 16 | -30.43% |
| 30 Sep, 23 | 23 | -14.81% |
| 30 Jun, 23 | 27 | 350.00% |
| 31 Mar, 23 | 6 | -45.45% |
| 31 Dec, 22 | 11 | 10.00% |
| 30 Sep, 22 | 10 | -9.09% |
| 30 Jun, 22 | 11 | -8.33% |
| 31 Mar, 22 | 12 | -20.00% |
| 31 Dec, 21 | 15 | 25.00% |
| 30 Sep, 21 | 12 | 20.00% |
| 30 Jun, 21 | 10 | -64.29% |
| 31 Mar, 21 | 28 | 40.00% |
| 31 Dec, 20 | 20 | 150.00% |
| 30 Sep, 20 | 8 | -60.00% |
| 30 Jun, 20 | 20 | 53.85% |
| 31 Mar, 20 | 13 | 18.18% |
| 31 Dec, 19 | 11 | 37.50% |
| 30 Sep, 19 | 8 | -60.00% |
| 30 Jun, 19 | 20 | -41.18% |
| 31 Mar, 19 | 34 | 112.50% |
| 31 Dec, 18 | 16 | -27.27% |
| 30 Sep, 18 | 22 | -18.52% |
| 30 Jun, 18 | 27 | 80.00% |
| 31 Mar, 18 | 15 | -16.67% |
| 31 Dec, 17 | 18 | - |
20 institutional shareholders have increased their position in IFRX stock as of 31 Mar 24 compared to 16 in the previous quarter (a 25.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 5 | -58.33% |
| 31 Dec, 23 | 12 | 50.00% |
| 30 Sep, 23 | 8 | 60.00% |
| 30 Jun, 23 | 5 | 25.00% |
| 31 Mar, 23 | 4 | -60.00% |
| 31 Dec, 22 | 10 | 11.11% |
| 30 Sep, 22 | 9 | 80.00% |
| 30 Jun, 22 | 5 | -44.44% |
| 31 Mar, 22 | 9 | - |
| 31 Dec, 21 | 9 | -10.00% |
| 30 Sep, 21 | 10 | -23.08% |
| 30 Jun, 21 | 13 | 85.71% |
| 31 Mar, 21 | 7 | 40.00% |
| 31 Dec, 20 | 5 | -50.00% |
| 30 Sep, 20 | 10 | -16.67% |
| 30 Jun, 20 | 12 | 50.00% |
| 31 Mar, 20 | 8 | 60.00% |
| 31 Dec, 19 | 5 | -28.57% |
| 30 Sep, 19 | 7 | - |
| 30 Jun, 19 | 7 | - |
| 31 Mar, 19 | 7 | -30.00% |
| 31 Dec, 18 | 10 | - |
| 30 Sep, 18 | 10 | 150.00% |
| 30 Jun, 18 | 4 | -50.00% |
| 31 Mar, 18 | 8 | - |
| 31 Dec, 17 | - | - |
5 institutional shareholders have reduced their position in IFRX stock as of 31 Mar 24 compared to 12 in the previous quarter (a -58.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 37 | -5.13% | 13,833,566 | -18.55% | 25.18% | 3.03% | 20 | 25.00% | 5 | -58.33% |
| 31 Dec, 23 | 39 | -7.14% | 16,983,545 | -10.14% | 28.84% | 2.62% | 16 | -30.43% | 12 | 50.00% |
| 30 Sep, 23 | 42 | 13.51% | 18,900,427 | 3.39% | 33.17% | 1.99% | 23 | -14.81% | 8 | 60.00% |
| 30 Jun, 23 | 37 | 48.00% | 18,281,096 | 434.94% | 40.83% | 70.08% | 27 | 350.00% | 5 | 25.00% |
| 31 Mar, 23 | 25 | -24.24% | 3,417,427 | -5.56% | 7.63% | 11.39% | 6 | -45.45% | 4 | -60.00% |
| 31 Dec, 22 | 33 | 22.22% | 3,618,593 | -6.12% | 8.19% | 10.76% | 11 | 10.00% | 10 | 11.11% |
| 30 Sep, 22 | 27 | 12.50% | 3,854,596 | -24.75% | 8.72% | 6.49% | 10 | -9.09% | 9 | 80.00% |
| 30 Jun, 22 | 24 | -25.00% | 5,122,402 | -19.31% | 11.59% | 5.62% | 11 | -8.33% | 5 | -44.44% |
| 31 Mar, 22 | 32 | -17.95% | 6,347,934 | -31.30% | 14.36% | 2.91% | 12 | -20.00% | 9 | - |
| 31 Dec, 21 | 39 | 11.43% | 9,240,311 | 4.53% | 22.20% | 5.55% | 15 | 25.00% | 9 | -10.00% |
| 30 Sep, 21 | 35 | -2.78% | 8,840,261 | -20.55% | 20.01% | 3.15% | 12 | 20.00% | 10 | -23.08% |
| 30 Jun, 21 | 36 | -7.69% | 11,127,489 | -18.37% | 25.18% | 1.55% | 10 | -64.29% | 13 | 85.71% |
| 31 Mar, 21 | 39 | 30.00% | 13,631,901 | 296.70% | 40.32% | 23.39% | 28 | 40.00% | 7 | 40.00% |
| 31 Dec, 20 | 30 | 30.43% | 3,436,304 | -1.96% | 13.13% | 8.22% | 20 | 150.00% | 5 | -50.00% |
| 30 Sep, 20 | 23 | -30.30% | 3,505,012 | 2.62% | 12.64% | 7.42% | 8 | -60.00% | 10 | -16.67% |
| 30 Jun, 20 | 33 | 50.00% | 3,415,584 | -31.93% | 13.05% | 3.53% | 20 | 53.85% | 12 | 50.00% |
| 31 Mar, 20 | 22 | 15.79% | 5,017,755 | -5.13% | 19.22% | 4.68% | 13 | 18.18% | 8 | 60.00% |
| 31 Dec, 19 | 19 | 11.76% | 5,289,055 | 16.51% | 20.26% | 6.64% | 11 | 37.50% | 5 | -28.57% |
| 30 Sep, 19 | 17 | -39.29% | 4,539,544 | 2.48% | 17.47% | 6.00% | 8 | -60.00% | 7 | - |
| 30 Jun, 19 | 28 | -39.13% | 4,429,492 | -69.47% | 17.06% | 0.55% | 20 | -41.18% | 7 | - |
| 31 Mar, 19 | 46 | 35.29% | 14,509,056 | 9.57% | 55.88% | 2.01% | 34 | 112.50% | 7 | -30.00% |
| 31 Dec, 18 | 34 | -10.53% | 13,241,403 | -0.98% | 52.77% | 1.94% | 16 | -27.27% | 10 | - |
| 30 Sep, 18 | 38 | 15.15% | 13,372,824 | 4.23% | 52.11% | 1.89% | 22 | -18.52% | 10 | 150.00% |
| 30 Jun, 18 | 33 | 17.86% | 12,829,829 | 29.91% | 52.52% | 3.05% | 27 | 80.00% | 4 | -50.00% |
| 31 Mar, 18 | 28 | 55.56% | 9,876,168 | -2.63% | 41.48% | 2.21% | 15 | -16.67% | 8 | - |
| 31 Dec, 17 | 18 | - | 10,142,925 | - | 43.33% | - | 18 | - | - | - |
InflaRx Peer Ownership
| Ticker | Company |
|---|---|
| FULC | Fulcrum Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| GBIO | Generation Bio Co. |
| GRTX | Galera Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| EYPT | EyePoint Pharmaceuticals, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| OCUP | Ocuphire Pharma, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| SLS | SELLAS Life Sciences Group, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| ERAS | Erasca, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| KRON | Kronos Bio, Inc. |
IFRX Ownership FAQ
Who Owns InflaRx?
InflaRx is owned by institutional shareholders (25.18%), insiders (7.34%), and public (67.48%). The largest institutional shareholder of InflaRx is SUVRETTA CAPITAL MANAGEMENT, LLC (10.44% of total shares) and the top mutual fund owner is INVESCO EXCHANGE-TRADED FUND TRUST (0.00% of total shares).
Who are the major institutional shareholders of InflaRx?
InflaRx's major institutional shareholders are SUVRETTA CAPITAL MANAGEMENT, LLC, EVERSEPT PARTNERS, LP, CITIGROUP INC, MORGAN STANLEY, and 683 CAPITAL MANAGEMENT, LLC. The top five shareholders own together 18.36% of the company's share outstanding.
How many InflaRx shareholders are there?
As of Mar 2024, there are 37 institutional shareholders of InflaRx.
What percentage of InflaRx is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
SUVRETTA CAPITAL MANAGEMENT, LLC owns 5.73M shares of InflaRx, representing 10.44% of the company's total shares outstanding, valued at $8.83M (as of Mar 2024).
What percentage of InflaRx is owned by EVERSEPT PARTNERS, LP?
As of Mar 2024, EVERSEPT PARTNERS, LP holds 1.31M shares of InflaRx (IFRX), compromising 2.38% of the company, valued at $2.01M.
What percentage of InflaRx is owned by CITIGROUP INC?
CITIGROUP INC is the third largest holder of InflaRx. The company owns 1.2M of the company's shares outstanding (worth $1.85M).